Protected from Colitis through Anti-Inflammatory Mechanisms

Background & Rationale

The role of omega-6 (n-6) and omega-3 (n-3) polyunsaturated fatty acids (PUFA) in the regulation of inflammation has been a topic of interest in the field of gastroenterology. While n-6 PUFA are known to promote inflammation, n-3 PUFA have been shown to have anti-inflammatory properties. The discovery of resolvins and protectins, potent anti-inflammatory lipid mediators derived directly from n-3 PUFA, has further highlighted the importance of n-3 PUFA in inflammation regulation. However, the relationship between n-3 PUFA tissue status and the formation of these anti-inflammatory mediators has not been fully explored.

Study Design

The study utilized a transgenic mouse model that endogenously biosynthesizes n-3 PUFA from n-6 PUFA, allowing for an increased n-3 PUFA tissue status. The mice were subjected to a colitis model, and the effects of the increased n-3 PUFA tissue status on inflammation and tissue injury were assessed. The study aimed to investigate the role of n-3 PUFA-derived lipid mediators in inflammation protection and to establish the fat-1 transgenic mouse as a new experimental model for the study of n-3 PUFA-derived lipid mediators.

Patient Population

The study did not involve human subjects, but rather a transgenic mouse model. The mice were genetically modified to express the fat-1 gene, which allows for the endogenous biosynthesis of n-3 PUFA from n-6 PUFA. This model enabled the researchers to study the effects of increased n-3 PUFA tissue status on inflammation and tissue injury in a controlled setting.

Key Findings

The study found that the transgenic mice with increased n-3 PUFA tissue status had significant formation of anti-inflammatory resolvins and effective reduction in inflammation and tissue injury in colitis. The endogenous increase in n-3 PUFA and related products did not decrease n-6 PUFA-derived lipid mediators, such as leukotriene B4 and prostaglandin E2. The observed inflammation protection was associated with decreased NF-kappa B activity and expression of TNF alpha, inducible NO synthase, and IL-1 beta, as well as enhanced muco-protection due to the higher expression of trefoil factor 3, Toll-interacting protein, and zonula occludens-1. The transgenic mice had 45% less tissue injury and 55% less inflammation compared to the wild-type mice.

Discussion

The study’s findings have implications for the understanding of the molecular mechanisms of inflammation protection afforded by n-3 PUFA. The results suggest that the anti-inflammatory effects of n-3 PUFA are not solely due to the inhibition of n-6 PUFA-derived eicosanoid formation, but rather through the formation of resolvins and protectins. The study also highlights the potential of the fat-1 transgenic mouse as a new experimental model for the study of n-3 PUFA-derived lipid mediators. In terms of safety and tolerability, the study did not report any adverse effects associated with the increased n-3 PUFA tissue status in the transgenic mice.

Authors’ Conclusions

The authors conclude that the increased n-3 PUFA tissue status in transgenic mice leads to significant formation of anti-inflammatory resolvins and effective reduction in inflammation and tissue injury in colitis. They suggest that the fat-1 transgenic mouse is a valuable new experimental model for the study of n-3 PUFA-derived lipid mediators and that the study’s findings add insight into the molecular mechanisms of inflammation protection afforded by n-3 PUFA.

Reference

Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, Serhan CN, Kang JX. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A 2006; 103(30): 11276-81. doi: 10.1073/pnas.0601280103.